Should you buy RGNT stock?
Last updated:
Based on market data through , StockInvest.us rates Regentis Biomaterials Ltd. (RGNT) as a Sell Candidate with a technical score of -4.47 on its -10 to +10 scale. The rating is unchanged from the previous daily evaluation.
- Sell signal since
- Price since signal Down 27.17%
- 3-month trend forecast Up 0.20%
- Easy Tracking In The Watchlist
Regentis Biomaterials Ltd. stock price ended at $1.85 on Monday, after losing 2.12%
(Market data through Aug 10, 2026)
The Regentis Biomaterials Ltd. stock price fell by -2.12% on the last day (Monday, 10th Aug 2026) from $1.89 to $1.85. It has now fallen 3 days in a row. During the last trading day the stock fluctuated 5.83% from a day low at $1.80 to a day high of $1.91. The price has fallen in 5 of the last 10 days and is down by -10.19% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -25 thousand shares and in total, 17 thousand shares were bought and sold for approximately $31.91 thousand.
The stock is at the lower part of a very wide and horizontal trend in the short term, and normally this may pose a good buying opportunity, though a breakdown through the bottom trend line at $1.29 will give a strong sell signal and a trend shift may be expected. Given the current horizontal trend, you can expect Regentis Biomaterials Ltd. stock with a 90% probability to be traded between $1.30 and $9.43 at the end of this 3-month period. A break of a horizontal trend is often followed by a large increase in the volume, and stocks seldom manage to go directly from the bottom of a trend up to the top. Stocks turning up in the middle of a horizontal trend are therefore considered to be potential runners.
RGNT Signals & Forecast
Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Regentis Biomaterials Ltd. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $1.92 and $2.83. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Monday, June 15, 2026, and so far it has fallen -80.32%. Further fall is indicated until a new bottom pivot has been found. Volume fell along with the price during the last trading day which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk. The very low volume increases the risk and reduces the other technical signals issued.
Support, Risk & Stop-loss for Regentis Biomaterials Ltd. stock
Regentis Biomaterials Ltd. finds support from accumulated volume at $1.78 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock may move very much during the day (volatility) and with periodic low trading volume this stock is considered to be "very high risk". During the last day, the stock moved $0.105 between high and low, or 5.83%. For the last week the stock has had daily average volatility of 9.99%.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (RGNT) For The Upcoming Trading Day Of Tuesday 11th
For the upcoming trading day on Tuesday, 11th we expect Regentis Biomaterials Ltd. to open at $1.85, and during the day (based on 14 day Average True Range), to move between $1.66 and $2.04, which gives a possible trading interval of +/-$0.388 (+/-23.42%) up or down from last closing price. If Regentis Biomaterials Ltd. takes out the full calculated possible swing range there will be an estimated 23.42% move between the lowest and the highest trading price during the day.
Since the stock is closer to the resistance from accumulated volume at $1.90 (2.70%) than the support at $1.78 (3.78%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.
Is Regentis Biomaterials Ltd. stock A Buy?
Regentis Biomaterials Ltd. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.
Current score:
-4.472
Sell Candidate
Unchanged
Predicted Fair Opening Price
Predicted fair opening price on August 11, 2026 - $1.85 ( 0.0901%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
RGNT Performance
Trading levels for RGNT
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 1.96 | 5.77% |
| R2 | 1.92 | 3.60% |
| R1 | 1.89 | 2.26% |
| Price | 1.85 | |
| S1 | 1.81 | -2.08% |
| S2 | 1.79 | -3.42% |
| S3 | 1.75 | -5.59% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 2.28 | 23.24% |
| R2 | 1.96 | 5.95% |
| R1 | 1.90 | 2.70% |
| Price | 1.85 | |
| S1 | 1.78 | -3.78% |
| S2 | 1.76 | -4.86% |
| S3 | 1.50 | -18.92% |
FAQ
Click here for our free guide on how to buy Regentis Biomaterials Ltd. Stock.
Buy RGNT